This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Christopher Ian Dallman: Innovator in Indole Derivatives
Introduction
Christopher Ian Dallman is a notable inventor based in Sandwich, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his work on indole derivatives. His innovative approach has led to the development of valuable compounds that have potential applications in medicine.
Latest Patents
Dallman holds a patent for "Indole derivatives," specifically focusing on eletriptan hydrobromide monohydrate. This invention provides a detailed formula along with processes for preparing, uses of, and compositions containing the monohydrate. His patent represents a significant advancement in the pharmaceutical industry, showcasing his expertise and dedication to innovation.
Career Highlights
Throughout his career, Dallman has been associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to collaborate with some of the brightest minds in the industry, further enhancing his contributions to drug development and innovation.
Collaborations
Dallman has worked closely with Ronald James Ogilvie, a fellow innovator in the field. Their collaboration has likely fostered a creative environment that encourages the development of groundbreaking solutions in pharmaceuticals.
Conclusion
Christopher Ian Dallman is a distinguished inventor whose work on indole derivatives has made a significant impact in the pharmaceutical sector. His dedication to innovation and collaboration continues to drive advancements in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile